CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment

Author:

Sakamoto Yuma1,Ishida Takashi23ORCID,Masaki Ayako1,Murase Takayuki1,Yonekura Kentaro4,Tashiro Yukie5,Tokunaga Masahito6,Utsunomiya Atae6,Ito Asahi3,Kusumoto Shigeru3,Iida Shinsuke3,Ueda Ryuzo7,Inagaki Hiroshi1ORCID

Affiliation:

1. Department of Pathology and Molecular Diagnostics, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan;

2. Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Morioka, Japan;

3. Department of Hematology and Oncology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan;

4. Department of Dermatology,

5. Department of Pathology, and

6. Department of Hematology, Imamura General Hospital, Kagoshima, Japan; and

7. Department of Tumor Immunology, School of Medicine, Aichi Medical University, Nagakute, Japan

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 73 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3